Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 8 | 2024 | 316 | 1.700 |
Why?
|
Tissue and Organ Procurement | 3 | 2022 | 218 | 0.460 |
Why?
|
Bronchiectasis | 1 | 2010 | 23 | 0.350 |
Why?
|
Scoliosis | 1 | 2010 | 134 | 0.320 |
Why?
|
Lung | 7 | 2024 | 1465 | 0.290 |
Why?
|
Graft Rejection | 2 | 2019 | 587 | 0.230 |
Why?
|
Pleural Effusion, Malignant | 1 | 2023 | 14 | 0.220 |
Why?
|
Graft Survival | 3 | 2021 | 530 | 0.200 |
Why?
|
Transplant Recipients | 2 | 2023 | 209 | 0.200 |
Why?
|
Scleroderma, Systemic | 1 | 2023 | 117 | 0.190 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 147 | 0.190 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 113 | 0.190 |
Why?
|
Ischemia | 1 | 2024 | 344 | 0.180 |
Why?
|
Lung Injury | 1 | 2022 | 122 | 0.180 |
Why?
|
Tissue Donors | 2 | 2022 | 495 | 0.180 |
Why?
|
Hypoxia | 2 | 2022 | 248 | 0.170 |
Why?
|
Organ Transplantation | 1 | 2020 | 162 | 0.150 |
Why?
|
Patient Selection | 1 | 2020 | 683 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 203 | 0.130 |
Why?
|
HLA Antigens | 1 | 2016 | 243 | 0.120 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 139 | 0.120 |
Why?
|
Autoantibodies | 1 | 2016 | 424 | 0.110 |
Why?
|
Pandemics | 1 | 2020 | 1100 | 0.100 |
Why?
|
Heart Transplantation | 1 | 2019 | 854 | 0.100 |
Why?
|
Immunotherapy | 1 | 2016 | 657 | 0.100 |
Why?
|
Postoperative Complications | 2 | 2024 | 3018 | 0.090 |
Why?
|
Humans | 14 | 2024 | 123254 | 0.090 |
Why?
|
Middle Aged | 7 | 2024 | 26073 | 0.090 |
Why?
|
Kartagener Syndrome | 1 | 2010 | 13 | 0.090 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2017 | 622 | 0.090 |
Why?
|
Respiratory Function Tests | 1 | 2010 | 195 | 0.090 |
Why?
|
Infant, Newborn | 1 | 2022 | 8112 | 0.080 |
Why?
|
Allografts | 2 | 2022 | 192 | 0.080 |
Why?
|
Retrospective Studies | 5 | 2024 | 16056 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2022 | 12165 | 0.070 |
Why?
|
Infant | 1 | 2022 | 12377 | 0.070 |
Why?
|
Child, Preschool | 1 | 2022 | 13918 | 0.070 |
Why?
|
Heart Failure | 1 | 2019 | 2131 | 0.060 |
Why?
|
Comorbidity | 1 | 2010 | 1498 | 0.060 |
Why?
|
Aged | 5 | 2024 | 19173 | 0.060 |
Why?
|
Adolescent | 1 | 2022 | 19131 | 0.060 |
Why?
|
Risk Factors | 3 | 2024 | 10036 | 0.050 |
Why?
|
Vital Capacity | 1 | 2023 | 76 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 147 | 0.050 |
Why?
|
Catheters, Indwelling | 1 | 2023 | 155 | 0.050 |
Why?
|
Child | 1 | 2022 | 24263 | 0.050 |
Why?
|
Female | 6 | 2024 | 65598 | 0.050 |
Why?
|
Collagen | 1 | 2022 | 317 | 0.050 |
Why?
|
Fibrosis | 1 | 2022 | 429 | 0.040 |
Why?
|
Male | 6 | 2024 | 60310 | 0.040 |
Why?
|
Risk Assessment | 2 | 2021 | 3336 | 0.040 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2019 | 51 | 0.040 |
Why?
|
Waiting Lists | 1 | 2020 | 225 | 0.040 |
Why?
|
Fibroblasts | 1 | 2022 | 884 | 0.040 |
Why?
|
Odds Ratio | 1 | 2021 | 1245 | 0.040 |
Why?
|
Polysomnography | 1 | 2019 | 142 | 0.040 |
Why?
|
Sampling Studies | 1 | 2016 | 74 | 0.030 |
Why?
|
Positron Emission Tomography Computed Tomography | 1 | 2017 | 78 | 0.030 |
Why?
|
Incidence | 1 | 2024 | 3052 | 0.030 |
Why?
|
Databases, Factual | 1 | 2021 | 1170 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 2015 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2016 | 229 | 0.030 |
Why?
|
Radiography, Thoracic | 1 | 2016 | 152 | 0.030 |
Why?
|
Age Factors | 1 | 2022 | 2806 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2023 | 2058 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2023 | 2852 | 0.030 |
Why?
|
Survival Rate | 1 | 2019 | 2001 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2017 | 483 | 0.030 |
Why?
|
Biopsy | 1 | 2017 | 1236 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 2016 | 1687 | 0.030 |
Why?
|
Adult | 2 | 2024 | 29079 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1232 | 0.020 |
Why?
|
Young Adult | 1 | 2021 | 8867 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2016 | 5049 | 0.020 |
Why?
|
United States | 1 | 2022 | 10663 | 0.020 |
Why?
|